Form 10-Q BIOGEN INC. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- Oil rises 1% on US-Iran deal doubts; IEA warns of supply glut
Biogen (BIIB) PT Lowered to $386 at Needham & Company
October 21, 2021 6:26 AM EDTNeedham & Company analyst Ami Fadia lowered the price target on Biogen (NASDAQ: BIIB) to $386.00 (from $398.00) while maintaining a Buy rating.
The analyst commented, "While near term earnings remain strong, driven by the MS franchise, Aduhelm's uptake is essentially pushed out to after CMS's final... More
Biogen (BIIB) PT Lowered to $390 at Oppenheimer
October 20, 2021 6:05 PM EDTOppenheimer analyst Jay Olson lowered the price target on Biogen (NASDAQ: BIIB) to $390.00 (from $450.00) while maintaining an Outperform rating.
The analyst commented, "Bolstered by a 3Q top- and bottom-line beat, BIIB outlined a number of steps to support the Aduhelm launch but deferred... More
